Pathophysiology of psoriasis: Coping endotoxins with bile acid therapy

Pathophysiology

Volumn 10, Issue 1, 2003, Pages 57-61

  Gyurcsovics, Klára ^a   Bertók, Lóránd ^b  

^a Endocrinology and Diabetology   (Hungary)

^b Jozsef Fodor National Center of Public Health   (Hungary)

Author keywords

Bile acids; Cytokines; Endotoxin; Psoriasis

Indexed keywords

BILE ACID; DEHYDROCHOLIC ACID; ENDOTOXIN;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC DISEASE; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PSORIASIS;

EID: 0344120248     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2003.07.001     Document Type: Article

References (33)

1. A. Dobozy, A. Horváth, J. Hunyadi, et al., Dermatology (in Hungarian), Eklektikon Kiadó, Budapest, 1998.
2. J. Hunyadi, Papulosquamous conditions, in: A. Dobozy, A. Horváth, J. Hunyadi, et al. (Eds.), Dermatology (in Hungarian), Eklektikon Kiadó, Budapest, 1998, pp. 211-242.
3. Cooper M.T. Epidermal lipid metabolism in psoriasis and lichen simplex. Brit. J. Dermatol. 94:1976;369-374.
4. Grütz O., Bürger M. Die Psoriasis als Stoffwechsel-problem. Klin. Wschr. 12:1933;373-377.
5. Lawrence C.M., Strange R.C., Summerly R.et al. Assessment of liver function using fasting bile salts concentrations in psoriasis prior to and during methotrexate therapy. Clin. Chim. Acta. 129:1983;341-351.
6. T. Yasuda, Internal factors and pustular psoriasis, in: Psoriasis: Proceedings of the Second International Symposium, New York Medical Books, New York, 1977.
7. Bjerke J.R., Haukenes G., Livden J.K., Matre R. Activated T lymphocytes, interferon, and retrovirus-like particles in psoriatic lesions. Arch. Dermatol. 119:1983;955-956.
8. Iversen O.J., Nissen-Meyer J., Dalen A.B. Characterization of virus-like particles from a psoriatic patient with respect to the possible presence of particle-associated RNA and RNA-directed DNA polymerase. Acta Pathol. Microbiol. Immunol. Scand. (Sect. B). 91:1983;413-417.
9. E.J. Stanbridge, A possible viral etiology for psoriasis, in: F.M. Farber, A.J. Cox (Eds.), Psoriasis, Grune & Stratton, New York, 1981, pp. 67-70.
10. Norholm A., Pedersen R. Infections and psoriasis. Acta Dermatol. Venerol. 32:1952;159-162.
11. Rosenberg W.E., Belew P.W. Microbial factors in psoriasis. Arch. Dermatol. 118:1982;143-144.
12. Lehmann P., Ruzicka Th. Neue entwicklungen in der therapie der psoriasis. Deutsches Ärzteblatt. 93:1996;3188-3193.
13. Mihatsch M.J., Wolff K. Consensus conference on cyclosporin A for psoriasis. Brit. J. Dermatol. 126:1992;621-623.
14. Kemény L., Dobozy A. The role of cytokines in the pathogenesis of psoriasis, new possibilities in the treatment (in Hungarian). LAM. 6:1996;196-201.
15. Hendel L., Larsen J.K., Ammitzboll T., Asboe-Hansen G. A study of cell proliferation kinetics in the small intestinal epithelium of psoriasis patients. Clin. Exp. Dermatol. 9:1984;329-335.
16. Baadsgaard O., Fischer G., Voorhees J.J. The role of the immune system in the pathogenesis of psoriasis. J. Invest. Dermatol. 95:1990;32-34.
17. Gottlieb A.B. Immunologic mechanism in psoriasis. J. Invest. Dermatol. 95:1990;18-19.
18. Nickoloff B.J. The cytokine network in psoriasis. Arch. Dermatol. 127:1991;871-884.
19. Terajima S. An important role of tumor necrosis factor-alpha in the induction of adhesion molecules in psoriasis. Arch. Dermatol. Res. 290:1998;246-252.
20. Belew P.W., Rosenberg E.W., Skinner R.B. Jr.et al. Endotoxemia in psoriasis. Arch. Dermatol. 118:1982;142-143.
21. W. Dixon, F.J. Massey, Introduction to Statistical Analysis, Wiley, Chichester, 1956.
22. Fredriksson T., Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica. 157:1978;238-244.
23. K. Morvay, Effect of bile acids and external environment on the development of experimental colon carcinoma (in Hungarian), Ph.D. Dissertation, Budapest, 1992.
24. Bertók L. Physico-chemical defense of vertebrate organisms: the role of bile acids in defense against bacterial endotoxins. Persp. Biol. Med. 21:1977;70-76.
25. L. Bertók, Role of bile in detoxification of lipopolysaccharide, in: D. Schlesinger (Ed.), Microbiology, ASM, Washington, 1980, pp. 91-93.
26. L. Bertók, Bacterial endotoxins and nonspecific resistance, in: J.L. Ninnemen (Ed.), Traumatic Injury: Infection and Other Immunologic Sequelae, University Park Press, Baltimore, MD, 1983, pp. 119-125.
27. Bertók L. Effect of bile acids on endotoxin in vitro and in vivo (physico-chemical defense). Ann. N.Y. Acad. Sci. 851:1998;408-410.
28. Bertók L. Bile acids and endotoxins: physicochemical defense of the organism (in Hungarian). Orv. Hetil. 140:1990;3-8.
29. L. Bertók, Natural Resistance: The Role of Bile Acids and Endotoxins (in Hungarian) 2. edition Scientia Kiadó, Budapest, 2002.
30. Bertók L. Role of endotoxins and bile acids in the pathogenesis of septic circulatory shock. Acta Chirurg. Hung. 36:1997;33-36.
31. Berczi I., Bertók L., Baintner K.et al. Failure of oral E. coli endotoxin to induce either specific tolerance or toxic symptoms in rats. J. Pathol. Bacteriol. 96:1968;481-486.
32. Chahill C.J. Prevention of postoperative renal failure in patients with obstructive jaundice: the role of bile salts. Br. J. Surg. 70:1983;590-596.
33. Kocsár L., Bertók L., Várterész V. Effect of bile acids on the intestinal absorption of endotoxin in rats. J. Bacteriol. 100:1969;220-223.